Announcements Trials
Browse Landscape

Phase

Phase 1 92Phase 2 68Phase 1/2 36Phase 3 10Phase NA 6Phase EARLY_PHASE1 2Phase 2/3 2Phase 4 1

Status

Unknown 15Recruiting 7Not yet recruiting 6Suspended 2Completed 2Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Breast Neoplasms 97Prostatic Neoplasms 41Neoplasms 40Glioblastoma 26Melanoma 24Head and Neck Neoplasms 24Brain Neoplasms 24Ovarian Neoplasms 18Squamous Cell Carcinoma of Head and Neck 17Lung Neoplasms 17Carcinoma, Renal Cell 17Carcinoma, Hepatocellular 17Glioma 16Pancreatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Leukemia, Myeloid, Acute 14Colorectal Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Urinary Bladder Neoplasms 10Lymphoma 10Uterine Cervical Neoplasms 9Polycystic Ovary Syndrome 9Lymphoma, Non-Hodgkin 9Fallopian Tube Neoplasms 9Endometrial Neoplasms 9Myelodysplastic Syndromes 8Multiple Myeloma 8Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 8Skin Neoplasms 7

Interventions

pembrolizumab 1Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Lymphoma, B-Cell × Clear all
NCT02981914 2024-04-22

Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation

University of Chicago

Phase EARLY_PHASE1 Completed
12 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, B-Cell

NCT02144623 2017-03-03

PREVAIL

Lund University Hospital

Phase EARLY_PHASE1 Completed
4 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡